NCT01102413View on ClinicalTrials.gov

Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia

PHASE3CompletedINTERVENTIONAL

Enrollment

351

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Iron Deficiency AnemiaChronic Kidney Disease

Interventions

DRUG

Monofer

Infusion or injections

DRUG

Iron Sulphate

Oral intake

Trial Locations (1)

Unknown

Pharmacosmos, Holbæk

Sponsors

Lead Sponsor

Pharmacosmos A/S

All Listed Sponsors

lead

Pharmacosmos A/S

INDUSTRY

NCT01102413 - Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia | Biotech Hunter | Biotech Hunter